Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases
暂无分享,去创建一个
B. Salehi | J. Sharifi‐Rad | M. Martorell | N. Martins | W. Cho | Gitishree Das | J. Patra | Z. Stojanovic-Radic | G. Leyva-Gómez | H. Cortés | Y. Singh | Marzieh Sharifi-Rad | M. D. Del Prado-Audelo | Z. Stojanović-Radić | M. Sharifi-Rad | Javad Sharifi‐Rad
[1] D. Quintanar-Guerrero,et al. In vitro cell uptake evaluation of curcumin-loaded PCL/F68 nanoparticles for potential application in neuronal diseases , 2019, Journal of Drug Delivery Science and Technology.
[2] D. Quintanar-Guerrero,et al. Comparative study of the release profiles of ibuprofen from polymeric nanocapsules and nanospheres , 2019, Journal of the Mexican Chemical Society.
[3] Jingyi Zhang,et al. Curcumin-loaded PEG-PDLLA nanoparticles for attenuating palmitate-induced oxidative stress and cardiomyocyte apoptosis through AMPK pathway , 2019, International journal of molecular medicine.
[4] S. Puttipipatkhachorn,et al. Development of curcumin floating beads with low density materials and solubilizers , 2019, Journal of Drug Delivery Science and Technology.
[5] Ying Xu,et al. Co-precipitation of calcium carbonate and curcumin in an ethanol medium as a novel approach for curcumin dissolution enhancement , 2019, Journal of Drug Delivery Science and Technology.
[6] R. Pop,et al. Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction , 2019, Oxidative medicine and cellular longevity.
[7] P. Cysewski,et al. Experimental and theoretical solubility advantage screening of bi-component solid curcumin formulations , 2019, Journal of Drug Delivery Science and Technology.
[8] M. Calmon,et al. Effect of curcumin-nanoemulsion associated with photodynamic therapy in breast adenocarcinoma cell line. , 2019, Bioorganic & medicinal chemistry.
[9] Kok-Gan Chan,et al. Curcumin Nanoformulations for Colorectal Cancer: A Review , 2019, Front. Pharmacol..
[10] M. González-Torres,et al. Formulations of Curcumin Nanoparticles for Brain Diseases , 2019, Biomolecules.
[11] B. Salehi,et al. The therapeutic potential of curcumin: A review of clinical trials. , 2019, European journal of medicinal chemistry.
[12] A. Kunnumakkara,et al. Non-Curcuminoids from Turmeric and Their Potential in Cancer Therapy and Anticancer Drug Delivery Formulations , 2019, Biomolecules.
[13] Shrikant Pawar,et al. Curcumin in combination with anti‐cancer drugs: A nanomedicine review , 2019, Pharmacological research.
[14] G. Ferns,et al. Curcumin in tissue engineering: A traditional remedy for modern medicine , 2018, BioFactors.
[15] A. Bishayee,et al. Advances in phytochemical delivery systems for improved anticancer activity. , 2019, Biotechnology advances.
[16] Yuehua Wu,et al. Curcumin ameliorates atherosclerosis in apolipoprotein E deficient asthmatic mice by regulating the balance of Th2/Treg cells. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[17] A. Angelova,et al. Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders , 2018, Medicines.
[18] A. Adedapo,et al. Cardioprotective Effects of Curcumin-Nisin Based Poly Lactic Acid Nanoparticle on Myocardial Infarction in Guinea Pigs , 2018, Scientific Reports.
[19] Leonardo Fernandes Fraceto,et al. Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.
[20] M. Rajabi,et al. Turmeric tonic as a treatment in scalp psoriasis: A randomized placebo‐control clinical trial , 2018, Journal of cosmetic dermatology.
[21] S. Atkin,et al. Curcumin in heart failure: A choice for complementary therapy? , 2018, Pharmacological research.
[22] A. Avan,et al. Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways , 2018, Journal of cellular physiology.
[23] Meili Zhai,et al. Curcumin attenuates IR-induced myocardial injury by activating SIRT3. , 2018, European review for medical and pharmacological sciences.
[24] Peiyang Li,et al. Curcumin Protects against Atherosclerosis in Apolipoprotein E-Knockout Mice by Inhibiting Toll-like Receptor 4 Expression. , 2018, Journal of agricultural and food chemistry.
[25] M. Garg,et al. Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial. , 2017, Metabolism: clinical and experimental.
[26] C. Morand,et al. Curcumin modulates endothelial permeability and monocyte transendothelial migration by affecting endothelial cell dynamics. , 2017, Free radical biology & medicine.
[27] Huaidong Hu,et al. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials , 2017, Nutrition Journal.
[28] S. Rossi,et al. Nanoparticle formulations to enhance tumor targeting of poorly soluble polyphenols with potential anticancer properties. , 2017, Seminars in cancer biology.
[29] N. Sharma,et al. Nanoformulations of curcumin: an emerging paradigm for improved remedial application , 2017, Oncotarget.
[30] Huiping Deng,et al. Curcumin pretreatment protects against PM2.5-induced oxidized low-density lipoprotein-mediated oxidative stress and inflammation in human microvascular endothelial cells , 2017, Molecular medicine reports.
[31] M. K. Swamy,et al. Leptadenia reticulata (Retz.) Wight & Arn. (Jivanti): Botanical, Agronomical, Phytochemical, Pharmacological, and Biotechnological Aspects , 2017, Molecules.
[32] A. Eatemadi,et al. Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines , 2017, Artificial cells, nanomedicine, and biotechnology.
[33] Zhiqiang Ma,et al. Curcumin as a potential protective compound against cardiac diseases , 2017, Pharmacological research.
[34] Zhigang Xie,et al. Relief of oxidative stress and cardiomyocyte apoptosis by using curcumin nanoparticles. , 2017, Colloids and surfaces. B, Biointerfaces.
[35] M. Farzaei,et al. Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective , 2017, International journal of nanomedicine.
[36] D. Kassuha,et al. Nanomedicine applied to cardiovascular diseases: latest developments , 2017, Therapeutic advances in cardiovascular disease.
[37] P. Subramani,et al. Curcumin Nanotechnologies and Its Anticancer Activity , 2017, Nutrition and cancer.
[38] H. Thu,et al. Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: A review of new trends and state-of-the-art. , 2017, Colloids and surfaces. B, Biointerfaces.
[39] Z. Qiao,et al. Protective effect of curcumin against myocardium injury in ischemia reperfusion rats , 2017, Pharmaceutical biology.
[40] Tian Zhang,et al. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[41] Xiaoxiong Zeng,et al. Food macromolecule based nanodelivery systems for enhancing the bioavailability of polyphenols , 2016, Journal of food and drug analysis.
[42] Madhukar B. Kolli,et al. Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension , 2016, Artificial cells, nanomedicine, and biotechnology.
[43] M. K. Swamy,et al. Patchouli (Pogostemon cablin Benth.): Botany, agrotechnology and biotechnological aspects , 2016 .
[44] Michael K Danquah,et al. Nano-formulations of drugs: Recent developments, impact and challenges. , 2016, Biochimie.
[45] H. Havel. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials , 2016, The AAPS Journal.
[46] G. Schneider,et al. Counting on Natural Products for Drug Design , 2016 .
[47] K. Thurecht,et al. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date , 2016, Pharmaceutical Research.
[48] I. Siddiqui,et al. Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy. , 2016, Molecular nutrition & food research.
[49] Reza Kazemi Oskuee,et al. Novel delivery system for natural products: Nano-curcumin formulations , 2016, Avicenna journal of phytomedicine.
[50] B. Ramírez-Wong,et al. Nano- and Micro-Particles by Nanoprecipitation: Possible Application in the Food and Agricultural Industries , 2016 .
[51] M. Nobre,et al. Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancer , 2016, Journal of oncology.
[52] Petra Schneider,et al. Counting on natural products for drug design. , 2016, Nature chemistry.
[53] Mohammad Shabib Akhtar,et al. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art , 2016, Journal of drug targeting.
[54] A. Sahebkar,et al. Opinion Paper: Nanotechnology: A Successful Approach to Improve Oral Bioavailability of Phytochemicals. , 2016, Recent patents on drug delivery & formulation.
[55] G. Zhai,et al. Oral bioavailability of curcumin: problems and advancements , 2016, Journal of drug targeting.
[56] Rania M. Hathout,et al. Exploring the use of nanocarrier systems to deliver the magical molecule; Curcumin and its derivatives. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[57] H. Rachmawati,et al. In Vitro Study on Antihypertensive and Antihypercholesterolemic Effects of a Curcumin Nanoemulsion , 2016, Scientia pharmaceutica.
[58] Yu Zhou,et al. Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation , 2016, PloS one.
[59] Saurabh Bhatia,et al. Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications , 2016 .
[60] A. Mitra,et al. Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment. , 2016, Toxicology and applied pharmacology.
[61] Pilar Ventosa-Andrés,et al. DRUG SOLUBILITY : IMPORTANCE AND ENHANCEMENT TECHNIQUES , 2016 .
[62] G. Basso,et al. Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles , 2016, Targeted Oncology.
[63] Lulu Wang,et al. Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies. , 2015, International journal of pharmaceutics.
[64] S. Nabavi,et al. Curcumin: a natural product for diabetes and its complications. , 2015, Current topics in medicinal chemistry.
[65] M. Salman,et al. Recent developments in curcumin and curcumin based polymeric materials for biomedical applications: A review. , 2015, International journal of biological macromolecules.
[66] M. Jaggi,et al. Therapeutic Applications of Curcumin Nanoformulations , 2015, The AAPS Journal.
[67] Qian Wang,et al. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals. , 2015, Chinese journal of natural medicines.
[68] M. Gremião,et al. Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease , 2015, International journal of nanomedicine.
[69] K. Chopra,et al. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant‐induced arthritis in rats , 2015, European journal of pain.
[70] S. Mahattanadul,et al. Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[71] Anil K Sood,et al. Nanotechnology: Future of Oncotherapy , 2015, Clinical Cancer Research.
[72] S. Rivera-Mancía,et al. Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications. , 2015, European journal of pharmacology.
[73] Yi Sun,et al. Effect of curcumin on permeability of coronary artery and expression of related proteins in rat coronary atherosclerosis heart disease model. , 2015, International journal of clinical and experimental pathology.
[74] A. Scholey,et al. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population , 2015, Journal of psychopharmacology.
[75] A. Gilani,et al. Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - a double blind randomized controlled trial - TAK-MetS trial. , 2015, Complementary therapies in medicine.
[76] E. Sikora,et al. Curcumin induces oxidation-dependent cell cycle arrest mediated by SIRT7 inhibition of rDNA transcription in human aortic smooth muscle cells. , 2015, Toxicology letters.
[77] G. Ferns,et al. An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial , 2015, Chinese Journal of Integrative Medicine.
[78] A. Molinari,et al. Liposomes as nanomedical devices , 2015, International journal of nanomedicine.
[79] V. Junyaprasert,et al. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs , 2015 .
[80] M. Maes,et al. Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change , 2015, European Neuropsychopharmacology.
[81] Victoria P. A. Johnstone,et al. Nanoparticle-mediated dual delivery of an antioxidant and a peptide against the L-Type Ca2+ channel enables simultaneous reduction of cardiac ischemia-reperfusion injury. , 2015, ACS nano.
[82] A. Sahebkar. Dual effect of curcumin in preventing atherosclerosis: the potential role of pro-oxidant–antioxidant mechanisms , 2015, Natural product research.
[83] R. Kumar,et al. Preparation and characterization of nanoemulsion encapsulating curcumin , 2015 .
[84] Yi-Sun Yang,et al. Lipid‐Lowering Effects of Curcumin in Patients with Metabolic Syndrome: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 2014, Phytotherapy research : PTR.
[85] K. Priyadarsini. The Chemistry of Curcumin: From Extraction to Therapeutic Agent , 2014, Molecules.
[86] M. Ghayour-Mobarhan,et al. Effects of supplementation with curcuminoids on serum copper and zinc concentrations and superoxide dismutase enzyme activity in obese subjects , 2014 .
[87] Y. Panahi,et al. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. , 2014, Complementary therapies in medicine.
[88] L. Giat,et al. High Concentration Nanocurcumin Fabrication By Wet Milling Method Curcumin With Glassball , 2014 .
[89] Brianna Coté,et al. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity. , 2014, Journal of pharmaceutical sciences.
[90] R. Mason,et al. Recent advances in curcumin nanoformulation for cancer therapy , 2014, Expert opinion on drug delivery.
[91] U. Krishnan,et al. Novel Resveratrol and 5-Fluorouracil Coencapsulated in PEGylated Nanoliposomes Improve Chemotherapeutic Efficacy of Combination against Head and Neck Squamous Cell Carcinoma , 2014, BioMed research international.
[92] A. Alizadeh,et al. Nanotechnology-Applied Curcumin for Different Diseases Therapy , 2014, BioMed research international.
[93] M. Dhanaraju,et al. Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine. , 2014, Asian Pacific journal of tropical biomedicine.
[94] N. Moustaid‐Moussa,et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. , 2014, The Journal of nutritional biochemistry.
[95] Ningping Wang,et al. Attenuation of Inflammatory Response and Reduction in Infarct Size by Postconditioning Are Associated With Downregulation of Early Growth Response 1 During Reperfusion in Rat Heart , 2014, Shock.
[96] Wim E Hennink,et al. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. , 2014, Biomaterials.
[97] S. Jirawatnotai,et al. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. , 2014, The Journal of nutritional biochemistry.
[98] Suk Fun Chin,et al. Preparation and Characterization of Starch Nanoparticles for Controlled Release of Curcumin , 2014 .
[99] A. A. Siddiqui,et al. Role of Natural Products in Drug Discovery Process , 2014 .
[100] J. Zingg,et al. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. , 2014, Atherosclerosis.
[101] De-xiang Liu,et al. Antidepressant-like effects of curcumin in chronic mild stress of rats: Involvement of its anti-inflammatory action , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[102] A. Sahebkar,et al. Curcuminoids Modulate Pro‐Oxidant–Antioxidant Balance but not the Immune Response to Heat Shock Protein 27 and Oxidized LDL in Obese Individuals , 2013, Phytotherapy research : PTR.
[103] Ranjeny Thomas,et al. Targeted delivery of curcumin for treating type 2 diabetes. , 2013, Molecular nutrition & food research.
[104] M. Williams. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 15th Edition Edited by M.J. O'Neil , Royal Society of Chemistry, Cambridge, UK ISBN 9781849736701; 2708 pages. April 2013, $150 with 1-year free access to The Merck Index Online. , 2013 .
[105] A. El-Wakf,et al. Efficacy of Curcumin in Reducing Risk of Cardiovascular Disease in High Fat Diet-Fed Rats , 2013 .
[106] F. Ahmad,et al. A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke , 2013, Protoplasma.
[107] C. Heckler,et al. Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients , 2013, Radiation research.
[108] M. Morsy,et al. Mechanisms of the Protective Effects of Curcumin against Indomethacin-Induced Gastric Ulcer in Rats , 2013, Pharmacology.
[109] I. Rahman,et al. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease. , 2013, Current medicinal chemistry.
[110] G. Ferns,et al. Effects of Supplementation with Curcuminoids on Dyslipidemia in Obese Patients: A Randomized Crossover Trial , 2013, Phytotherapy research : PTR.
[111] J. Zingg,et al. Molecular mechanisms of hypolipidemic effects of curcumin , 2013, BioFactors.
[112] S. Yadav,et al. Turmeric (curcumin) remedies gastroprotective action , 2013, Pharmacognosy reviews.
[113] Ningping Wang,et al. Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction , 2012, British journal of pharmacology.
[114] Darrick S. H. L. Kim,et al. Curcuminoids in neurodegenerative diseases. , 2012, Recent patents on CNS drug discovery.
[115] Jong Chun Park,et al. Curcumin reduces the cardiac ischemia-reperfusion injury: involvement of the toll-like receptor 2 in cardiomyocytes. , 2012, The Journal of nutritional biochemistry.
[116] A. Goel,et al. A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis , 2012, Phytotherapy research : PTR.
[117] Catherine A. Sugar,et al. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study , 2012, Alzheimer's Research & Therapy.
[118] Fang Wang,et al. Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs , 2012, Pharmaceutical Research.
[119] Ventola Cl,et al. The nanomedicine revolution: part 1: emerging concepts. , 2012, P & T : a peer-reviewed journal for formulary management.
[120] C. Morand,et al. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. , 2012, Molecular nutrition & food research.
[121] G. Zhai,et al. Advances in nanotechnology-based delivery systems for curcumin. , 2012, Nanomedicine.
[122] Jignasa K. Savjani,et al. Drug Solubility: Importance and Enhancement Techniques , 2012, ISRN pharmaceutics.
[123] S. Jirawatnotai,et al. Curcumin Extract for Prevention of Type 2 Diabetes , 2012, Diabetes Care.
[124] S. Shyue,et al. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. , 2012, Molecular nutrition & food research.
[125] R. DiSilvestro,et al. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people , 2012, Nutrition Journal.
[126] Liang Shen,et al. The pharmacology of curcumin: is it the degradation products? , 2012, Trends in molecular medicine.
[127] B. Aggarwal,et al. Discovery of curcumin, a component of golden spice, and its miraculous biological activities , 2012, Clinical and experimental pharmacology & physiology.
[128] R. Kumria,et al. Nanocrystals: Current Strategies and Trends , 2012 .
[129] C. L. Ventola,et al. The nanomedicine revolution: part 1: emerging concepts. , 2012, P & T : a peer-reviewed journal for formulary management.
[130] Murali M. Yallapu,et al. Curcumin nanoformulations: a future nanomedicine for cancer. , 2012, Drug discovery today.
[131] B. Aggarwal,et al. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials , 2012, The AAPS Journal.
[132] Viorel Simion,et al. Curcumin and a Morus alba Extract Reduce Pro‐Inflammatory Effects of Resistin in Human Endothelial Cells , 2011, Phytotherapy research : PTR.
[133] T. Ha,et al. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. , 2011, Molecular nutrition & food research.
[134] M. Fujita,et al. A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[135] D. Chirio,et al. Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique , 2011, Journal of microencapsulation.
[136] D. Gjertson,et al. Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study , 2011, Clinical Cancer Research.
[137] Kurt E. Geckeler,et al. Polymer nanoparticles: Preparation techniques and size-control parameters , 2011 .
[138] F. Aqil,et al. Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention , 2011, Cancer Prevention Research.
[139] R. Benya,et al. Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia , 2011, Cancer Prevention Research.
[140] Chuanbing Shi,et al. Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin , 2011, Cancer investigation.
[141] T. Chiba,et al. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers , 2011, Cancer Chemotherapy and Pharmacology.
[142] B. Aggarwal,et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer , 2011, Cancer Chemotherapy and Pharmacology.
[143] G. Bar-Sela,et al. Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer , 2010, Nutrition and cancer.
[144] Murali M. Yallapu,et al. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. , 2010, Journal of colloid and interface science.
[145] P. Neri,et al. Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up , 2010, Clinical ophthalmology.
[146] C. Mohanty,et al. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. , 2010, Biomaterials.
[147] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[148] M. Fujita,et al. Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[149] S. Onoue,et al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. , 2010, Journal of pharmaceutical sciences.
[150] Wei Xu,et al. Altered profiles of gene expression in curcumin-treated rats with experimentally induced myocardial infarction. , 2010, Pharmacological research.
[151] Y-M Yu,et al. Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[152] J. McCarthy. Nanomedicine and Cardiovascular Disease , 2010, Current cardiovascular imaging reports.
[153] M. Mouret-Reynier,et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer , 2010, Cancer biology & therapy.
[154] Sudesh Kumar Yadav,et al. Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.
[155] R. Lotan,et al. Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. , 2009, Carcinogenesis.
[156] G. Gupta,et al. Solubility Enhancement – Eminent Role in Poorly Soluble Drugs , 2009 .
[157] Dayong Wu,et al. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. , 2009, The Journal of nutrition.
[158] W. Wongcharoen,et al. The protective role of curcumin in cardiovascular diseases. , 2009, International journal of cardiology.
[159] Y. Nasuhara,et al. Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[160] S. Kulkarni,et al. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes , 2009, Pharmacology Biochemistry and Behavior.
[161] L. Qin,et al. Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cells induced by Chol:MbetaCD. , 2009, Biochemical and biophysical research communications.
[162] B. Aggarwal,et al. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. , 2009, The international journal of biochemistry & cell biology.
[163] B. Aggarwal,et al. Curcumin and cancer: an "old-age" disease with an "age-old" solution. , 2008, Cancer letters.
[164] R. Lai,et al. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. , 2008, Journal of biomedical materials research. Part A.
[165] Razelle Kurzrock,et al. Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer , 2008, Clinical Cancer Research.
[166] S. Chakrabarti,et al. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. , 2008, American journal of physiology. Endocrinology and metabolism.
[167] W. D. de Jong,et al. Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.
[168] D. Liao,et al. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells , 2008, Acta Pharmacologica Sinica.
[169] A. Troxel,et al. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. , 2008, Journal of the American Academy of Dermatology.
[170] M. Fujita,et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. , 2008, The Journal of clinical investigation.
[171] V. Mok,et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. , 2008, Journal of clinical psychopharmacology.
[172] J. Eckel,et al. Role of curcumin in health and disease , 2008 .
[173] T. Santoso,et al. The effect of curcumin on lipid level in patients with acute coronary syndrome. , 2008, Acta medica Indonesiana.
[174] V. Mok,et al. Curcumin effects on blood lipid profile in a 6-month human study. , 2007, Pharmacological research.
[175] Robert A Newman,et al. Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.
[176] Ju Han Kim,et al. Curcumin Attenuates Inflammatory Responses of TNF-α-Stimulated Human Endothelial Cells , 2007 .
[177] B. Aggarwal,et al. The molecular targets and therapeutic uses of curcumin in health and disease , 2007 .
[178] B. Aggarwal,et al. Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.
[179] A. Gescher,et al. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine , 2007, Cancer Chemotherapy and Pharmacology.
[180] Robert W. Thompson,et al. Oral Administration of Diferuloylmethane (Curcumin) Suppresses Proinflammatory Cytokines and Destructive Connective Tissue Remodeling in Experimental Abdominal Aortic Aneurysms , 2006, Annals of vascular surgery.
[181] M. Nair,et al. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer , 2006, Expert opinion on therapeutic targets.
[182] Xiaoping Yang,et al. Curcumin Inhibits Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[183] M. Korabiowska,et al. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[184] Ricky A. Sharma,et al. Curcumin: the story so far. , 2005, European journal of cancer.
[185] C. Yeh,et al. Inhibition of NFκB Activation with Curcumin Attenuates Plasma Inflammatory Cytokines Surge and Cardiomyocytic Apoptosis Following Cardiac Ischemia/Reperfusion1 , 2005 .
[186] C. Yeh,et al. Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. , 2005, The Journal of surgical research.
[187] Udaykumar Ranga,et al. Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription* , 2004, Journal of Biological Chemistry.
[188] A. Lumsden,et al. Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. , 2004, Journal of vascular surgery.
[189] R. Middleton,et al. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. , 2004, Journal of alternative and complementary medicine.
[190] R. Puvanakrishnan,et al. Curcumin modulates free radical quenching in myocardial ischaemia in rats. , 2004, The international journal of biochemistry & cell biology.
[191] S. Fujisawa,et al. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. , 2004, Anticancer research.
[192] G. Amidon,et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. , 2004, Molecular pharmaceutics.
[193] Thorsteinn Loftsson,et al. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. , 2002, International journal of pharmaceutics.
[194] J. Quiles,et al. Curcuma longa Extract Supplementation Reduces Oxidative Stress and Attenuates Aortic Fatty Streak Development in Rabbits , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[195] N. Biswas,et al. Evaluation of Ophthacare® eye drops—a herbal formulation in the management of various ophthalmic disorders , 2001, Phytotherapy research : PTR.
[196] S. Jee,et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.
[197] A. R. Kulkarni,et al. Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[198] J. Miquel,et al. An hydroalcoholic extract of Curcuma longa lowers the apo B/apo A ratio Implications for atherogenesis prevention , 2000, Mechanisms of Ageing and Development.
[199] D. Dickson. The story so far… , 2000, Nature.
[200] J. Quiles,et al. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. , 1999, Atherosclerosis.
[201] R. Prasad,et al. Efficacy of Curcumin in the Management of Chronic Anterior Uveitis , 1999, Phytotherapy research : PTR.
[202] Jen-kun Lin,et al. Biotransformation of curcumin through reduction and glucuronidation in mice. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[203] J. Quiles,et al. An ethanolic‐aqueous extract of Curcuma longa decreases the susceptibility of liver microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits , 1998, BioFactors.
[204] R. Kuttan,et al. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. , 1992, Indian journal of physiology and pharmacology.
[205] M. Dikshit,et al. Anti-thrombotic effect of curcumin. , 1985, Thrombosis research.
[206] V. Ravindranath,et al. Metabolism of curcumin--studies with [3H]curcumin. , 1981, Toxicology.
[207] J. Plummer,et al. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. , 1978, Xenobiotica; the fate of foreign compounds in biological systems.
[208] V. Lampe,et al. Studien über Curcumin , 1913 .